AYTU BioPharma, Inc.
AYTU • NASDAQ
AYTU BioPharma, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Joshua R. Disbrow, with a market cap of $27.5M.
Market Cap$27.5M
Employees150.0
CEOJoshua R. Disbrow
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 13, 2026 · in a monthQ3 2026
Financials
AYTU BioPharma, Inc. FAQ
Common questions about AYTU BioPharma, Inc.
AYTU BioPharma, Inc. is scheduled to report earnings for Q3 2026 on May 13, 2026. Analysts estimate revenue of $12.6M.
AYTU BioPharma, Inc. has approximately 150 employees.